Delivery Order SPE2DB25D3012-SPE2DB25FWZVR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,494.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 28, 2025, with performance fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dexmethylphenidate ER 5 mg capsules (100-count units) with a ceiling value of $1,601.40. This firm fixed price delivery order, with an ultimate completion date of August 29, 2025, represents a pediatric neurological medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The award carries no set-aside designation, indicating it was competitively...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Dexmethylphenidate ER 10 mg capsules in a quantity of 100 units at a ceiling value of $3,265.34. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, reflecting the vendor's established capability to meet federal pharmaceutical procurement requirements through open competition. The contract will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) valued at $3,238.65. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The contract calls for ultimate completion by July 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a contract value of $1,250.14. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The work is to be completed by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,143.20 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 25 mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitive, non-set-aside delivery order utilizes firm fixed price terms and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 30 mg capsules (100 count) on August 5, 2025, with a ceiling value of $2,111.70 and an ultimate completion date of August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,226.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count bottles) with a contract ceiling value of $1,772.16. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 15 mg capsules (100 count) valued at $2,024.24, with a performance period through August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its Conshohocken, Pennsylvania corporate office location. The award represents a pediatric neurological medication commonly used to treat attention deficit...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZVRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dexmethylphenidate ER 5 mg capsules (100-count units) with a ceiling value of $1,091.12. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. As a child delivery order, this award falls under a larger Indefinite Delivery Contract framework. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery/Indefinite Quantity contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract vehicle serves as a comprehensive pharmaceutical supply mechanism for federal medical procurement, enabling the company to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other government healthcare systems. Dexmethylphenidate is a central nervous system stimulant commonly used in the treatment of attention deficit hyperactivity disorder, reflecting the diverse therapeutic categories covered under DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/8/25 |